References

1 Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54(3):438-463.

2 Linder MC. Nutrition and metabolism of fats. In: Linder MC (editor). Nutritional biochemistry and metabolism. 2nd. ed. Norwalk, CT: Appleton & Lange, 1991:51-83.

3 Innis SM. Essential dietary lipids. In: Ziegler EE, Filer LJ, Jr. (editors).Present knowledge in Nutrition. 7th. ed., Washington, DC: ILSI Press, 1996:58-66.

4 Shamberger RJ. Erythrocyte Fatty Acid Studies in Patients. J Advance Med 1997; 10(3): 195-205.

5 GSDL data. Copy Available upon request.

6 Horrobin DF. Loss of delta-6-desaturase activity as a key factor in aging. Med Hypotheses 1981;7(9):1211-1220.

7 Sprecher H. Interconversions between 20- and 22-carbon n-3 and n-6 fatty acids via 4-desaturase independent pathways. In: Sinclar A, Gibson R (editors), Essential fatty acids and eicosanoids. Champaign, IL: American Oil Chemists' Society, 1992:18-22.

8 Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990;82(3):209-216.

9 Cf. Chapter 6, "Taming the Savage Cell," in Simopoulos, A. The Omega Plan. New York: HarperCollins, 1998:61-74, for a more complete discussion.

10 Horrobin DF. A biochemical basis for alcoholism and alcohol-induced damage including the fetal alcohol syndrome and cirrhosis: interference with essential fatty acid and prostaglandin metabolism. Med Hypotheses 1980;6(9):929-942.

11 Hollenbeck C, Reaven GM. Variation of insulin stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987;64:1169-1173.

12 Sears, Barry. The Zone: A Dietary Roadmap. New York: HarperCollins, 1995.

13 Mandell AJ. Non-equilibrium behavior of some brain enzyme and receptor systems. Annu Rev Pharmacol Toxicol 1984;24:237-274.

14 Block ER, Edwards D. Effect of plasma membrane fluidity on serotonin transport by endothelial cells. Am J Physiol 1987; 253(5,Pt 1):C672-C678.

15 Storlien LH, Kriketos AD, Calvert GD, Baur LA, Jenkins AB. Fatty acids, triglycerides and syndromes of insulin resistance. Prostaglandins Leukot Essent Fatty Acids 1997;57(4-5): 379-385.

16 Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 1991;88(11): 4835-4839.

17 Gibson RA, Makrides M, Neumann MA, Simmer K, Mantzioris E, James MJ. Ratios of linoleic acid to alpha-linolenic acid in formulas for term infants. J Pediatr 1994;125(5,Pt 2):S48-S55.

18 Agren JJ, Tormala ML, Nenonen MT, Hanninen OO. Fatty acid composition of erythrocyte, platelet, and serum lipids in strict vegans. Lipids 1995;30(4):365-369.

19. Hornstra G, Al MD, van Houwelingen AC, Foreman-van Drongelen MM. Essential fatty acids in pregnancy and early human development. Eur J Obstet Gynecol Reprod Biol 1995; 61(1):57-62.

20 Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995; 6(3):232-237.

21 Ogburn PL, Turner SI, William's PP, Johnson SB, Holman RT. Essential fatty acid patterns in preeclampsia. Zentralbl Gynakol 1986; 108(16):983-989.

22 Gitlin MJ, Pasnau RO. Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. Am J Psychiatry 1989;146(11):1413-1422.

23 Makrides M, Neumann MA. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996;50(6):352-357.

24 Gibson RA, Neumann MA, Makrides M Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997; 51(9):578-584.

25 Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol 1978;20(4):421-426.

26 Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila) 1987;26(8):406-411.

27 Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995; 62(4): 761-768.

28 Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 1996;59(4-5):915-920.

29 Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 1996;97(4):1129-1133.

30 Virkkunen ME, Horrobin DF, Jenkins DK, Manku MS. Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders. Biol Psychiatry 1987;22(9):1087-1096.

31 Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995; 62(1):1-9.

32 Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996; 31(Suppl):S157-S161.

33 Fielding R. Depression and acute myocardial infarction: a review and reinterpretation. Soc Sci Med 1991;32(9):1017-1028.

34 Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 1995;30(Suppl 8): 98-101.

35 Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116(8):609-614.

36 Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274(17):1363-1367.

37 Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial. Lancet 1989;2(8666):757-761.

38 Deck C, Radack K. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial. Arch Intern Med 1989; 49(8):1857-1862.

39 Radack K, Deck C, Huster G. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Intern Med 1989; 111(9):757-758.

40 Radack K, Deck C, Huster G. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial. Arch Intern Med 1991;151(6):1173-1180.

41 Li XL, Steiner M. Dose response of dietary fish oil supplementations on platelet adhesion. Arterioscler Thromb 1991;11(1): 39-46.

42 Radack KL, Deck CC, Huster GA. n-3 fatty acid effects on lipids, lipoproteins, and apolipoproteins at very low doses: results of a randomized controlled trial in hypertriglyceridemic subjects. Am J Clin Nutr 1990; 51(4):599-605.

43 Rambjor GS, Walen AI, Windsor SL, Harris WS. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect offish oil in humans. Lipids 1996;31(Suppl): S45-S49.

44 Harris WS, Lu G, Rambjor GS, Walen AI, Ontko JA, Cheng Q, Windsor SL. Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 1997;66(2):254-260.

45 Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, Dinarello CA, Schaefer EJ. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 1993 ;92(1):105-113.

46 De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA Jr, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids 1995;52(2-3):191-195.

47 De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins inhuman endothelial cells. Arterioscler Thromb 1994; 14(11):1829-1836.

48 Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277(6):472-477.

49 Storlien LH, Kriketos AD, Calvert GD, Baur LA, Jenkins AB. Fatty acids, triglycerides and syndromes of insulin resistance. Prostaglandins Leukot Essent Fatty Acids 1997;57(4-5): 379-385.

50 Fanaian M, Szilasi J, Storlien L, and Calvert GD. The effect of a modified fat diet on insulin resistance and metabolic parameters in type II diabetes. Diabetologica 1996;39(1):A7.

51 Das UN. Auto-immunity and prostaglandins. Int J Tissue React 1981;3(2):89-94.

52 Das UN. Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essent Fatty Acids 1994; 51(3):207-213.

53 Robinson DR, Xu LL, Tateno S, Guo M, Colvin RB. Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 1993; 34(8):1435-1444.

54 Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int 1989;36(4):653-660.

55. Kremer JM. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 1996;31(Suppl): S243-S247.

56 Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti inflammatory drugs. Clinical and immune correlates. Arthritis Rheum 1995;38(8):1107-1114.

57 Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;33(6):810-820.

For a limited time you can schedule a to talk with a licensed doctor or clinician regarding your condition. Please complete a preliminary and schedule your consultation NOW!